Rachel V. Spanton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rachel V. Spanton has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Alexander W. Katz
Department of Ophthalmology and Visual Sciences, University of Wisconsin—Madison, Madison, Wisconsin, USA
2 shared publications - Amy Hartman
Department of Communication Sciences and Disorders, University of Wisconsin-Madison, Madison, WI, USA
2 shared publications Andrea M. Weiler
Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA
2 shared publicationsAngelica Sun
Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, USA
2 shared publicationsAnika Shah
Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, USA
2 shared publicationsAnn M. Mitzey
Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, USA
2 shared publications
Latest Publications
- Open Access
- 13 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Author Correction: Prenatal Zika virus exposure disrupts social-emotional development and cortical visual function in infant macaques
- 13 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessAuthor Correction: Prenatal Zika virus exposure disrupts social-emotional development and cortical visual function in infant macaques
- Open Access
- 29 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Prenatal Zika virus exposure disrupts social-emotional development and cortical visual function in infant macaques
Prenatal Zika virus (ZIKV) exposure can result in outcomes ranging from severe birth defects to subtle developmental delays, yet the underlying mechanisms remain unclear. Using a translational rhesus macaque model, we assess visual, auditory, and neurodevelopmental outcomes through 12 months of age following first-trimester ZIKV inoculation. Pregnant macaques, either flavivirus-naive or with prior dengue virus (DENV) exposure, are inoculated with Asian or African ZIKV lineages. Maternal viremia duration, placental viral burden, and neutralizing antibody titers vary but are not associated with developmental outcomes. At 12 months, ZIKV-exposed infants exhibit altered maternal attachment behaviors and reduced inhibition toward novel sensory stimuli. Visual evoked potentials are impaired at 3 months but normalize by 12 months; hearing loss is more frequent but not statistically significant. These outcomes are driven by ZIKV exposure itself, independent of maternal infection characteristics. Our findings highlight the limitations of maternal biomarkers in risk prediction and support incorporating infant-focused developmental outcomes in studies of maternal interventions.
- 29 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessPrenatal Zika virus exposure disrupts social-emotional development and cortical visual function in infant macaques
Prenatal Zika virus (ZIKV) exposure can result in outcomes ranging from severe birth defects to subtle developmental delays, yet the underlying mechanisms remain unclear. Using a translational rhesus macaque model, we assess visual, auditory, and neurodevelopmental outcomes through 12 months of age following first-trimester ZIKV inoculation. Pregnant macaques, either flavivirus-naive or with prior dengue virus (DENV) exposure, are inoculated with Asian or African ZIKV lineages. Maternal viremia duration, placental viral burden, and neutralizing antibody titers vary but are not associated with developmental outcomes. At 12 months, ZIKV-exposed infants exhibit altered maternal attachment behaviors and reduced inhibition toward novel sensory stimuli. Visual evoked potentials are impaired at 3 months but normalize by 12 months; hearing loss is more frequent but not statistically significant. These outcomes are driven by ZIKV exposure itself, independent of maternal infection characteristics. Our findings highlight the limitations of maternal biomarkers in risk prediction and support incorporating infant-focused developmental outcomes in studies of maternal interventions.